8-K - Sarepta Therapeutics, Inc. | StockGist

Current Report Details

Event Type

Financial Results

Disclosure

Mandatory

Variant

8-K

Items Reported

2.02

of this report. Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 99.1 Press Release dated January 12, 2026 104 The cover pa

Financial Results

Exhibits (2)

8-K

99.1

EX-99.1